ClinicalTrials.gg
RecruitingNCT07817745Updated Sep 14, 2026

Outcomes of Neurosurgical Tone Management

An observational study in Spastic/Dystonic Quadriplegia and Cerebral Palsy (CP), sponsored by Boston Children's Hospital. Recruiting at 1 site in United States. Open to participants aged 6 Years to 25 Years. Per ClinicalTrials.gov, last updated 2026-09-14.

Sponsored by Boston Children's Hospital · Observational

From the registry’s dates

  • Started Jun 2024; still recruiting 2 years 4 months later.
Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
100
Ages
6 Years to 25 Years
Sex
All
01

Study summary

Patients with spastic/dystonic quadriplegia (GMFCS IV/V) are often severely disabled by their tone, and require surgical tone management to improve quality of life, allow for better function, improve comfort, and range of motion. This has historically been limited to Intrathecal Baclofen (ITB) pumps, which are effective for up to 85% of patients but carry significant morbidity / complications and are not appropriate for many patients. More recently, combined dorsal/ventral rhizotomy (CR) has emerged as an alternative means for tone control, a one-time surgery with no required hardware implantation. However, more information is needed regarding long-term outcomes of this procedure in addition to comparative outcomes of ITB. This information will lead to improved patient selection, counseling, and care. This is a prospectively enrolled, single-center study, involving survey administration and clinical observation of outcomes pre- and post-surgery.

02

Conditions studied

  • Spastic/Dystonic Quadriplegia
  • Cerebral Palsy (CP)

Keywords

  • CP
  • Cerebral Palsy
  • Tone Management
  • Dystonic
  • Spastic
  • Spasticity
  • Intrathecal Baclofen Pump
  • Combined Dorsal/Ventral Rhizotomy
03

In context

Muscle Spasticity

621 studies on the registry are indexed under Muscle Spasticity; 127 are open to participants now.

This study's planned enrollment of 100 is above the median of 60 across 137 observational studies indexed under Muscle Spasticity.

Browse Muscle Spasticity studies →

Lead sponsor

Boston Children's Hospital is the lead sponsor of 608 studies on the registry; 147 are open to participants now.

Of its 32 completed or terminated interventional studies of FDA-regulated products, 19 (59%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients will be recruited from the Cerebral Palsy and multidisciplinary tone management clinic.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Any patients undergoing intrathecal baclofen pump insertion or combined dorsal ventral rhizotomy at Boston Children's Hospital.
  • Must be at least 6 years of age at time of enrollment

Exclusion criteria

Exclusion Criteria:

-

05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Improved Spasticity Score

    We will study changes in Spasticity using the Modified Ashworth Scale in participants over the course of this study.

    Time frame: From enrollment to 5 years

  2. Improved Dystonia Score

    We will use the Barry Albright Dystonia Scale to measure changes in dystonia in participants over the course of this study.

    Time frame: From enrollment to 5 years.

Secondary outcomes

  1. Overall Quality of Life Improvements

    We will use the CP-Child survey to measure quality of life changes in participants over the course of this study. Specifically looking at trends in caregiver satisfaction with hygiene, and comfort.

    Time frame: From enrollment to 5 years

  2. Reduced Surgical Complications

    We will review outcomes for our participants to quantify surgical complications such as infection, malfunction, re-operation, spinal fluid leak, prolonged urinary retention, muscle wasting, and decubitus ulcer formation.

    Time frame: From enrollment to 5 years.

07

Study locations

1 of 1 sites recruiting
  • Boston Children's Hospital
    Boston, Massachusetts 02115, United States
    Recruiting
    • Adam Porter, MPH · Contactadam.porter@childrens.harvard.edu · 617-919-6013
    • Weston Northam, MD · Principal investigator
    • Kristin Buxton, PNP · Sub investigator
    • Juliani Mariani, MD · Sub investigator
    • Scellig Stone, MD, PhD · Sub investigator
    • Carley Vuillermin, MBBS, MPH, FRACS · Sub investigator
08

References and documents

Publications

  • Ahluwalia R, Bass P, Flynn L, Martin E, Riordan H, Lawrence A, Naftel RP. Conus-level combined dorsal and ventral lumbar rhizotomy for treatment of mixed hypertonia: technical note and complications. J Neurosurg Pediatr. 2020 Oct 9;27(1):102-107. doi: 10.3171/2020.6.PEDS20295. Print 2021 Jan 1. PubMed 33036004 ↗
  • Abdel Ghany WA, Nada M, Mahran MA, Aboud A, Mahran MG, Nasef MA, Gaber M, Sabry T, Ibrahim MH, Taha MH. Combined Anterior and Posterior Lumbar Rhizotomy for Treatment of Mixed Dystonia and Spasticity in Children With Cerebral Palsy. Neurosurgery. 2016 Sep;79(3):336-44. doi: 10.1227/NEU.0000000000001271. PubMed 27244465 ↗
  • Albright AL, Tyler-Kabara EC. Combined ventral and dorsal rhizotomies for dystonic and spastic extremities. Report of six cases. J Neurosurg. 2007 Oct;107(4 Suppl):324-7. doi: 10.3171/PED-07/10/324. PubMed 17941499 ↗

Individual participant data

Plan to share: Undecided — The study is currently undecided about IPD sharing due to IRB and participant confidentiality considerations, entity-level legal requirements, and the ongoing status of the study.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 14, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07817745
Responsible party
Weston Thomas Northam (Assistant Professor of Neurosurgery, Harvard Medical School, Boston Children's Hospital) — Principal investigator
First posted
Sep 14, 2026
Start date
Jun 26, 2024
Primary completion
Jul 1, 2030 (estimated)
Completion
Jan 1, 2031 (estimated)
Last update
Sep 14, 2026

Study contacts

Adam Porter, Research Manager, MPH
Contact
adam.porter@childrens.harvard.edu
617-919-6013
Weston Northam, MD
principal investigator · Boston Children's Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion